This report aims to provide a comprehensive presentation of the global market for Gene Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Drugs. This report contains market size and forecasts of Gene Therapy Drugs in global, including the following market information:
Global Gene Therapy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Neuromuscular Disease Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy Drugs include F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical?Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio and Nightstar Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy Drugs Market Segment Percentages, by Type, 2022 (%)
- Neuromuscular Disease
- Genetic Disease
- Other
Global Gene Therapy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy Drugs Market Segment Percentages, by Application, 2022 (%)
Global Gene Therapy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Therapy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F. Hoffmann-La Roche AG
- Novartis International AG
- Gilead Sciences, Inc.
- Ultragenyx Pharmaceutical?Inc.
- Applied Genetic Technologies Corp
- Audentes Therapeutics
- BioMarin Pharmaceutical
- Bluebird Bio
- Nightstar Therapeutics
- Sangamo Therapeutics
- Spark Therapeutics
- uniQure
- VBL Therapeutics
- Voyager Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy Drugs, market overview.
Chapter 2: Global Gene Therapy Drugs market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
